"As with gabapentin, dialysis has been utilized to treat pregabalin neurotoxicity and myoclonic activity  . Fifth, a threshold effect for the development of myoclonic activity with gabapentin and pregabalin has been previously reported  . This is consistent with the concept that adverse events for specific AEDs may require an individual threshold concentration which may be within the reference range   . "
[Show abstract][Hide abstract] ABSTRACT: Gabapentin, an AED approved for the adjunctive treatment of partial seizures with/without secondary generalization and for the treatment of postherpetic neuralgia, is frequently used off-label for the treatment of both psychiatric and pain disorders. Since gabapentin is cleared solely by renal excretion, dosing requires consideration of the patient's renal function. Myoclonic activity may occur as a complication of gabapentin toxicity, especially with acute kidney injury or end-stage renal disease. We report 2 cases of myoclonic activity associated with gabapentin toxicity in the setting of renal disease which resolved with discontinuation of gabapentin and treatment with hemodialysis and peritoneal dialysis. As gabapentin has multiple indications and off-label uses, an understanding of myoclonus, neurotoxicity, and renal dosing is important to clinicians in multiple specialties.
[Show abstract][Hide abstract] ABSTRACT: Maximum a posteriori (MAP) estimation of depth based on the
Bayesian approach is described. The authors investigate simulated
annealing in a hierarchical pyramid to accelerate the convergence. They
also utilize an unobservable line process to recover the piecewise
continuous depth map over the image plane. Simulation results are
provided using random dot diagrams as well as synthesized images
Neural Networks, 1990., 1990 IJCNN International Joint Conference on; 07/1990
Note: This list is based on the publications in our database and might not be exhaustive.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.